0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cold-chain Pharma Market by Pharma Product, Services, Temperature Range, Transportation - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666010
UP TO EUR$697USDGBP OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cold-chain Pharma Market grew from USD 7.89 billion in 2023 to USD 8.85 billion in 2024. It is expected to continue growing at a CAGR of 12.65%, reaching USD 18.18 billion by 2030.

The cold-chain pharma market centers on the temperature-controlled storage and transportation of pharmaceutical products, ensuring they maintain efficacy and safety from production to consumption. With the increasing complexity of biologic drugs, vaccines, and other temperature-sensitive pharmaceuticals, the necessity for robust cold-chain solutions is paramount to prevent degradation and ensure therapeutic efficacy. Its application spans from manufacturing to last-mile delivery, providing a critical infrastructure that ensures compliance with stringent regulatory standards. The end-use scope includes pharmaceutical companies, healthcare providers, and logistic partners striving to preserve the integrity of medical products.

Current market insights highlight the demand for biologics and personalized medicine as key growth drivers, necessitating sophisticated cold-chain logistics. Innovations such as IoT-enabled monitoring devices, blockchain for secure data sharing, and AI-driven predictive analytics offer potential opportunities. Companies investing in these technologies can enhance operational efficiencies, ensure real-time temperature tracking, and minimize risk, providing competitive advantage. Despite rapid growth, significant challenges persist including high operational costs, infrastructure limitations in emerging economies, and regulatory complexities. Addressing these requires strategic partnerships, optimizing logistics processes, and investing in advanced technologies.

Opportunities abound in regions like Asia-Pacific and Latin America, where improving logistics infrastructure and increasing demand for vaccines present growth avenues. Research and innovation could focus on developing energy-efficient cooling systems and sustainable packaging, reflecting a growing emphasis on environmental impact. Companies might also explore digital twin technologies to simulate and optimize logistics and storage conditions, reducing waste and enhancing efficiency.

The market is characterized by intense competition and rapid technological advancement. Companies should prioritize agility and continual process innovations to maintain relevance. Strategic collaborations across the supply chain can bolster capabilities, and comprehensive market analytics can inform strategic decisions, helping to navigate the evolving landscape and address emerging challenges effectively.

Understanding Market Dynamics in the Cold-chain Pharma Market

The Cold-chain Pharma Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing demand for storage of temperature-sensitive drugs and products
    • Stringent government regulations for pharmaceutical product storage and transportation
    • Increasing government initiatives for R&D activities
  • Market Restraints
    • High cost of execution for cold storage areas and maintenance
  • Market Opportunities
    • Advancement in vaccine development, monoclonal antibodies, and biologics
    • Integration of IoT and blockchain in pharma cold chain
  • Market Challenges
    • Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional

Exploring Porter’s Five Forces for the Cold-chain Pharma Market

Porter’s Five Forces framework further strengthens the insights of the Cold-chain Pharma Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cold-chain Pharma Market

External macro-environmental factors deeply influence the performance of the Cold-chain Pharma Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cold-chain Pharma Market

The Cold-chain Pharma Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cold-chain Pharma Market

The Cold-chain Pharma Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cold-chain Pharma Market

The Cold-chain Pharma Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold-chain Pharma Market, highlighting leading vendors and their innovative profiles. These include AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S, AmerisourceBergen Corporation, Cavalier Logistics, Inc. by Mitsubishi Logistics, Continental AG, CWT Ltd., DB Schenker, Deutsche Post AG, DHL International GmbH, FedEx Corporation, HCL Technologies Limited, Helapet ltd., JWD InfoLogistics Public Co. Ltd., Keppel Telecommunications & Transportation Ltd,, Kerry Logistics Network Limited by SF Holding Co., Ltd., Kuehne + Nagel Management AG, OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited, SCG Logistics Management Co Ltd., Tiong Nam Logistics Holdings Berhad, United Parcel Service, Inc., VersaCold Logistics Services, WHA Group, Ych Group, and Yusen Logistics Group.

Market Segmentation & Coverage

This research report categorizes the Cold-chain Pharma Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Pharma Product
    • Biologics
    • Over-the-Counter Medicines
    • Prescribed Drugs
    • Raw Materials & Bulk Pharmaceuticals
  • Services
    • Transportation
    • Warehousing & VAS
  • Temperature Range
    • Ambient
    • Refrigerated
      • Frozen
      • Liquid-Phase Liquid Nitrogen Conditions
      • Ultra-Frozen
      • Vapour-Phase Liquid Nitrogen
  • Transportation
    • Air-ways
    • Road
    • Sea-Ways
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for storage of temperature-sensitive drugs and products
5.1.1.2. Stringent government regulations for pharmaceutical product storage and transportation
5.1.1.3. Increasing government initiatives for R&D activities
5.1.2. Restraints
5.1.2.1. High cost of execution for cold storage areas and maintenance
5.1.3. Opportunities
5.1.3.1. Advancement in vaccine development, monoclonal antibodies, and biologics
5.1.3.2. Integration of IoT and blockchain in pharma cold chain
5.1.4. Challenges
5.1.4.1. Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cold-chain Pharma Market, by Pharma Product
6.1. Introduction
6.2. Biologics
6.3. Over-the-Counter Medicines
6.4. Prescribed Drugs
6.5. Raw Materials & Bulk Pharmaceuticals
7. Cold-chain Pharma Market, by Services
7.1. Introduction
7.2. Transportation
7.3. Warehousing & VAS
8. Cold-chain Pharma Market, by Temperature Range
8.1. Introduction
8.2. Ambient
8.3. Refrigerated
8.3.1. Frozen
8.3.2. Liquid-Phase Liquid Nitrogen Conditions
8.3.3. Ultra-Frozen
8.3.4. Vapour-Phase Liquid Nitrogen
9. Cold-chain Pharma Market, by Transportation
9.1. Introduction
9.2. Air-ways
9.3. Road
9.4. Sea-Ways
10. Americas Cold-chain Pharma Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cold-chain Pharma Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cold-chain Pharma Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. COLD-CHAIN PHARMA MARKET RESEARCH PROCESS
FIGURE 2. COLD-CHAIN PHARMA MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. COLD-CHAIN PHARMA MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. COLD-CHAIN PHARMA MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COLD-CHAIN PHARMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COLD-CHAIN PHARMA MARKET DYNAMICS
TABLE 7. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY OVER-THE-COUNTER MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY PRESCRIBED DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY RAW MATERIALS & BULK PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY WAREHOUSING & VAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AMBIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY FROZEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY LIQUID-PHASE LIQUID NITROGEN CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ULTRA-FROZEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY VAPOUR-PHASE LIQUID NITROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY AIR-WAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY ROAD, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COLD-CHAIN PHARMA MARKET SIZE, BY SEA-WAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 45. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 46. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 47. CANADA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 52. MEXICO COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES COLD-CHAIN PHARMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 70. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 72. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 73. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 74. CHINA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 78. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 79. INDIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 85. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 87. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 89. JAPAN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 115. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 117. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 118. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 119. THAILAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 133. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 135. DENMARK COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 136. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 138. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 140. EGYPT COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 141. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 143. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 145. FINLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 148. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 150. FRANCE COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 155. GERMANY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 163. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 164. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 165. ITALY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 176. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 178. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 179. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 180. NORWAY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 181. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 183. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 184. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 185. POLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 188. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 189. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 190. QATAR COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 208. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 210. SPAIN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 223. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 225. TURKEY COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY PHARMA PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY REFRIGERATED, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM COLD-CHAIN PHARMA MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
TABLE 236. COLD-CHAIN PHARMA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. COLD-CHAIN PHARMA MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cold-chain Pharma Market, which are profiled in this report, include:
  • AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S
  • AmerisourceBergen Corporation
  • Cavalier Logistics, Inc. by Mitsubishi Logistics
  • Continental AG
  • CWT Ltd.
  • DB Schenker
  • Deutsche Post AG
  • DHL International GmbH
  • FedEx Corporation
  • HCL Technologies Limited
  • Helapet ltd.
  • JWD InfoLogistics Public Co. Ltd.
  • Keppel Telecommunications & Transportation Ltd,
  • Kerry Logistics Network Limited by SF Holding Co., Ltd.
  • Kuehne + Nagel Management AG
  • OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
  • SCG Logistics Management Co Ltd.
  • Tiong Nam Logistics Holdings Berhad
  • United Parcel Service, Inc.
  • VersaCold Logistics Services
  • WHA Group
  • Ych Group
  • Yusen Logistics Group

Methodology

Table Information

This website uses cookies to ensure you get the best experience. Learn more